Two Sigma Investments’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$152M Buy
1,558,807
+1,137,072
+270% +$115M 0.12% 191
2025
Q4
$33.6M Buy
421,735
+412,628
+4,531% +$27.1M 0.05% 492
2025
Q3
$425K Buy
+9,107
New +$357K ﹤0.01% 3062
2024
Q4
Sell
-22,895
Closed -$1.04M 3439
2024
Q3
$1.04M Buy
22,895
+138
+0.6% +$6.01K ﹤0.01% 2098
2024
Q2
$883K Sell
22,757
-2,400
-10% -$89.7K ﹤0.01% 2058
2024
Q1
$811K Sell
25,157
-64,800
-72% -$1.92M ﹤0.01% 2082
2023
Q4
$2.58M Buy
89,957
+15,643
+21% +$376K 0.01% 1349
2023
Q3
$2.06M Buy
74,314
+14
+0% +$415 0.01% 1371
2023
Q2
$1.99M Sell
74,300
-29,460
-28% -$723K 0.01% 1441
2023
Q1
$2.25M Buy
103,760
+76,560
+281% +$1.89M 0.01% 1311
2022
Q4
$648K Sell
27,200
-111,254
-80% -$2.37M ﹤0.01% 1912
2022
Q3
$2.73M Buy
138,454
+83,950
+154% +$1.84M 0.01% 1006
2022
Q2
$1.06M Sell
54,504
-86,377
-61% -$1.68M ﹤0.01% 1518
2022
Q1
$3.59M Buy
140,881
+13,436
+11% +$292K 0.01% 1084
2021
Q4
$3.21M Buy
127,445
+14,011
+12% +$395K 0.01% 1528
2021
Q3
$3.12M Sell
113,434
-8,372
-7% -$244K 0.01% 1580
2021
Q2
$3.87M Buy
121,806
+101,274
+493% +$3.53M 0.01% 1353
2021
Q1
$942K Buy
+20,532
New +$921K ﹤0.01% 2380

Other funds holding RVMD

Two Sigma Investments's RVMD Position: Q1 2026 in Review

Two Sigma Investments increased its Revolution Medicines (RVMD) stake by 270% in Q1 2026, buying an estimated $115M and bringing the position to 1,558,807 shares worth $152M. The position accounts for 0.12% of the portfolio, ranked #191.

Two Sigma Investments first reported a position in RVMD in Q1 2021 and has held it in 18 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Two Sigma Investments held 1,558,807 shares of Revolution Medicines worth $152M as of Q1 2026.
  • Two Sigma Investments bought 1,137,072 Revolution Medicines shares in Q1 2026, an estimated $115M.
  • Revolution Medicines made up 0.12% of Two Sigma Investments's portfolio in Q1 2026, its #191 holding.
  • Two Sigma Investments first reported a position in Revolution Medicines in Q1 2021 and has held it in 18 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.